A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).

This LC-MS-based approach provides a simple, sensitive and fast analytical tool for characterizing CDG disorders in a routine clinical biochemistry while improving diagnostic accuracy and speeding clinical decision-making.